Rigel Pharmaceuticals, Inc. RIGL
NASDAQ · United States · Health Technology
$47.53-0.62 (-1.29%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | 0.88 | 0.09 | +903.9% | $78.70M | +42.4% | +8.1%$37.43→$40.48 |
| Q1 2026 | 2026-05-05 | 0.44 | 0.87 | -49.4% | — | — | -9.7%$29.54→$26.67 |
| Q4 2025 | 2026-03-03 | 1.12 | 1.20 | -6.7% | — | — | -14.4%$34.62→$29.63 |
| Q3 2025 | 2025-11-04 | 1.46 | 0.94 | +55.3% | — | — | +23.5%$30.65→$37.85 |
| Q2 2025 | 2025-08-05 | 3.28 | 1.41 | +132.6% | — | — | — |
| Q1 2025 | 2025-05-06 | 0.63 | 0.09 | +600.0% | — | — | — |
| Q4 2024 | 2025-03-04 | 0.80 | 0.58 | +37.9% | — | — | — |
| Q3 2024 | 2024-11-07 | 0.70 | 0.06 | +1,066.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.